Long Covid – Into the Third Year As the COVID-19 pandemic reaches the end of its third year, and as COVID-related mortality in North America wanes, long Covid and its disabling symptoms are attracting more attention. Some individuals report symptoms lasting more than 2 years, and a subset report continuing disability. This article will provide an update on long Covid, with a particular focus on disease prevalence, disability, symptom clustering and risk factors. It will also discuss the longer-term outlook for individuals with long Covid. https://meridian.allenpress.com/jim...d-Into-the-Third-Year?redirectedFrom=fulltext Open source version: https://www.munichre.com/ca-life/en/perspectives/2023/long-covid---into-the-third-year-.html
"Familiar": When you don't count some chronic illnesses as chronic illnesses, you will find fewer chronic illnesses than there are. Turns that when you don't try hard, when most in the profession are committed to denial, not much happens, especially if you insist on never doing things differently. But since it's not costing insurers much with most patients getting zero help or support, they won't be putting any pressure to solve this. There is a threshold of pain and suffering that the system will tolerate. Like how until emergency departments aren't overrun, nothing may as well be happening. Below that threshold, nothing happens. Just straight up nothing. The system is already maxed out, doesn't have any room to do anything more, but the very existence of things is decided based on their willingness to do something, so nothing happens because nothing happens. In a way this is far more savage than dystopian stories like the Hunger games.
Further article by this author, though no specific mention of ME/CFS — The Long-term Complications of Covid-19 Infection (2024) Meagher, Timothy Context.—. As the Covid-19 pandemic continues into its 4th year, reports of long-term morbidity and mortality are now attracting attention. Recent studies suggest that Covid-19 survivors are at increased risk of common illnesses, such as myocardial infarction, diabetes mellitus and autoimmune disorders. Mortality may also be increased. This article will review the evidence that supports some of these observations and provide an opinion about their validity and their relevance to insured cohorts. Link | PDF (Journal of Insurance Medicine) [Open Access]
